Consolidation with bortezomib and dexamethasone following risk-adapted melphalan and stem cell transplant in systemic AL amyloidosis

Amyloid. 2011 Jun:18 Suppl 1:135-6. doi: 10.3109/13506129.2011.574354050.
No abstract available

MeSH terms

  • Boronic Acids / administration & dosage
  • Boronic Acids / therapeutic use*
  • Bortezomib
  • Combined Modality Therapy
  • Dexamethasone / administration & dosage
  • Dexamethasone / therapeutic use*
  • Humans
  • Melphalan / administration & dosage
  • Melphalan / therapeutic use*
  • Pyrazines / administration & dosage
  • Pyrazines / therapeutic use*
  • Stem Cell Transplantation*

Substances

  • Boronic Acids
  • Pyrazines
  • Bortezomib
  • Dexamethasone
  • Melphalan